Tube Investments of India invests ₹75 crore in subsidiary 3xper Innoventure via compulsorily convertible preference shares.
Mr. N Govindarajan co-invests ₹25 crore in the pharmaceutical CDMO subsidiary to scale up operations.
Investment executed through supplementary agreement dated 23rd April 2026 at face value of ₹100 per CCPS.
Transaction subject to conditions precedent as per the supplementary agreement between the parties.